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Background: Chronic pelvic pain (CPP), a common gynaecological presentation, may be due to bladder
pain syndrome (BPS) or the co-existence of BPS and endometriosis, known as the ‘evil twins syndrome’.
Objectives: To estimate the prevalence of BPS and the co-existence of BPS and endometriosis in women
with CPP.
Data sources: We searched until March 2012: The Cochrane Library, DARE (1997e2012), EMBASE (1980
e2012), Medline (1950e2012), PSYCHINFO (1806e2012), Web of knowledge (1900e2012), LILACS
(1982e2012) and SIGLE (1990e2012) with no language restrictions. We manually searched through
bibliographies and conference proceedings of the International Continence Society.
Study selection: Observational studies of women suffering from CPP, who were not pregnant or suffering
from cancer, who underwent a laparoscopy and cystoscopy to investigate their symptoms. Study se-
lection, data extraction and quality assessment was performed independently by two reviewers. Sta-
tistical analysis was performed to estimate prevalence and conﬁdence intervals (CI).
Results: Nine studies were included with 1016 patients with CPP. Study quality and diagnostic assessment
varied. The mean prevalence of BPS was 61% (range 11e97%, CI 58e64%, I2 ¼ 98%). The mean prevalence
of endometriosis was 70% (range 28e93%, CI 67e73%, I2 ¼ 93%) and co-existing BPS and endometriosis
was 48% (range 16e78%, CI 44e51%, I2 ¼ 96%).
Conclusion: Almost two thirds of women presenting with CPP have BPS. Large variations in prevalence
may be due to variable study selection and quality. Clinicians need to actively investigate patients for BPS,
a condition that appears to co-exist with endometriosis.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Background
The diagnosis and treatment of chronic pelvic pain (CPP) has a
large ﬁnancial burden on health care economies. Bladder pain
syndrome (BPS) is a recognised cause of CPP. It can have a huge
impact on quality of life and sexual function.1ﬁdence interval; CPP, chronic
of Interstitial Cystitis/Painful
onal Institute of diabetes and
S, painful bladder syndrome;
ews and meta-analyses; PUF,
n.
Unit, Queen Mary, University
Kingdom. Tel.: þ44 207 882
ur).
ciates Ltd. Published by Elsevier LtBPS is deﬁned as the symptoms of CPP, bladder pressure or
discomfort along with at least one other urinary symptom in the
absence of any identiﬁable pathology or infection.2,3 This deﬁnition
was proposed by the European Society for the Study of Interstitial
Cystitis/Painful Bladder Syndrome (ESSIC) in 2008. The condition
can be further classiﬁed by cystoscopy grading and biopsy results.
BPS was formerly known as interstitial cystitis (IC) and painful
bladder syndrome (PBS). It has an unknown aetiology with a re-
ported prevalence between 5 and 16 per 100,000 of the popula-
tion.4,5 The prevalence of BPS amongst women with CPP is
unknown. The co-existence of diseases in CPP, such as BPS and
endometriosis, described by Chung et al. as the ‘evil twins syn-
drome’6,7 can make management very difﬁcult.8 While the term
‘the evil twin syndrome’ is not a medical deﬁnition, it conveys the
misery of the co-existence of these two chronic pain conditions.
The purpose of this systematic review was to estimate the
prevalence of BPS in women suffering from CPP. Secondarily wed. All rights reserved.
801 records identified 
through database searching 
597 records screened 
13 full text articles screened 
for eligibility 
9 studies included in 
qualitative synthesis 
4 studies excluded: 
1 study – primary outcome not 
measured 
1 study – patients did not match 
inclusion criteria 
2 studies – same data used 
584 records excluded 
204 duplicate articles 
manually identified 
Fig. 1. Study selection for a systematic review on prevalence of bladder pain syndrome
amongst women with chronic pelvic pain.
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REVIEWestimated the prevalence of endometriosis and the co-existence of
BPS and endometriosis within this group of women.
2. Methods
Our systematic review was conducted and reported in accordance with the
PRISMA statement.9
3. Data sources
A search through the following databases was performed until
March 2012: The Cochrane Library, DARE (1997e2012), EMBASE
(1980e2012), Medline (1950e2012), PSYCHINFO (1806e2012),
Web of knowledge (1900e2012) and LILACS (1982e2012). Grey
literature was searched through SIGLE (1990e2012). There were no
language restrictions.
3.1. Search strategy
We used MeSH headings and keywords for ‘chronic pelvic pain’
and ‘chronic pain’ combined using the Boolean operator ‘and’ with
the terms ‘interstitial cystitis’ or ‘painful bladder syndrome’ or
‘bladder pain syndrome’ or ‘urinary frequency’ or ‘urinary urgency’.
The search was restricted to those studies involving female pa-
tients. A hand search of bibliographies from relevant articles and
conference proceedings of the International Continence Society
was performed to identify articles not electronically cited, as
prevalence studies are not well indexed in database searches.
3.2. Study selection
Relevant studies on CPP were identiﬁed which met the
following criteria:
3.3. Participants
Women suffering from chronic pelvic pain with, or without, uri-
nary symptoms suggestive of IC, PBS or BPS, who were not pregnant
or suffering from cancer, who underwent a laparoscopy and cystos-
copy to investigate their symptoms. Patients diagnosed solely on
intravesical potassium sensitivity test (PST) were excluded. CPP was
deﬁned as intermittent or constant pain in the lower abdomen or
pelvis of at least 6 months duration, not occurring exclusively with
menstruation or intercourse and not associated with pregnancy.10
3.4. Outcome
Most of the studies were performed prior to introduction of the
BPS disease nomenclature, but for the purpose of this review all
thosewith ICwere considered to have a symptombased diagnosis of
BPS, as this would logically happen under the new disease classiﬁ-
cation. BPS was deﬁned according to the 1987 National Institute of
diabetes and digestive and kidney diseases (NIDDK) criteria. The
patient needed to have glomerulations on cystoscopy or a classic
Hunner’s ulcer, and either pain associated with the bladder or uri-
nary urgency. Glomerulations are punctuate petechial hemorrhages
on the bladder wall.11 These were diagnosed after two minutes of
bladder distension under anaesthesia. At least ten glomerulations
were needed in at least three quadrants of the bladder.12
3.5. Study selection
A systematic review was performed on the prevalence of BPS in
women with chronic pelvic pain. This included cross-sectional
studies, which are neither prospective nor retrospective butmeasure the given condition at one point in time. Cohort studies
were also included as it is possible to get prevalence ﬁgures from
the baseline data collection phase.
3.6. Data extraction and quality assessment
The data were independently extracted by two reviewers (SAT,
KK) using a pre-designed data collection form. Data were collected
for patient characteristics (number of participants, age and
ethnicity), study details (study design, location, setting, and
participant recruitment as part of the study quality assessment to
assess possible selection bias) and outcomes assessed (diagnostic
tools and rates of BPS, endometriosis and co-existing pathology).
Quality assessment was performed to assess the overall quality
of the studies used in this systematic review. It was carried out by
one reviewer and checked by a second reviewer. Studies not pub-
lished in English were translated by individuals with command of
the relevant language.13 Data from one study was extracted from a
conference abstract14 where the full article could not be obtained. A
quality assessment checklist was developed to evaluate internal
validity using the following characteristics15,16: (a) Study design to
determine if BPS assessment had been performed prospectively to
Fig. 2. Quality of studies included in the systematic review of the prevalence of
bladder pain syndrome and endometriosis.
Table 1
Study characteristics for papers included in the systematic review of bladder pain syndrome and endometriosis.
Study Country Mean age in years
(age range)
Ethnicity Number
of patient
Duration of study
(months)
Source of
recruitment
Cheng 2012 Australia 30 Not documented 150 29 Specialist clinic
Chung 2002 USA 19e62 Not documented 60 12 Specialist clinic
Chung 2005 USA 18e60 Not documented 178 24 Specialist clinic
Clemons 2002 USA 35.2 (20e53) 73% Caucasian, 16%
Hispanic, 2% African
American, 9% other
45 7 Operating list
Paulson 2011 USA Not documented Not documented 284 72 Operating list
Rackow 2009 USA 13e25 96% Caucasian, 4%
African-American
28 168 Operating list
Shahmohamady 2005 USA 36 (20e60) Not documented 92 Not documented Specialist clinic
Stanford 2005 USA 32.7 Not documented 64 12 Community
gynaecology
clinic
Villegas 2011 Columbia 32.6 (17e53) Not documented 115 26 Specialist clinic
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REVIEWminimise recall bias; (b) Adequacy of sampling by assessing
whether participant recruitment was random or consecutive; (c)
Sufﬁciently high response rate (>80%); (d) Use of diagnostic criteria
to diagnose BPS to ensure participants response rates are a true
representation of the underlying condition; (e) Sample size calcu-
lation so as to ascertain prevalence reliably. A study was considered
‘high quality’ if it complied with 3/5 quality criteria.17 External
validity was considered separately as the representativeness of the
sample for the general population (source of sample).8
3.7. Data synthesis
The prevalence and 95% conﬁdence interval (CI) was computed
for each study. Heterogeniety was assessed using I2 using the
Metadisc statistical software package.18 Pooled results were given
for information only as the results of individual studies were too
heterogenous to be used as combined results. Results with I2 > 50%
are considered highly heterogenous.
4. Results
The search identiﬁed 801 citations (Fig. 1). After removal of
duplicates there were 597 citations, of which 13 were deemed
relevant and their full papers were retrieved. Four studies were
excluded; in one only the secondary outcome of co-existing BPS
and endometriosis was measured, in another the presenting con-
dition was BPS rather than CPP and two studies reported the same
patient population, as conﬁrmed by the corresponding author. Nine
studies were included in the systematic review.
4.1. Study characteristics
The nine included observational studies were performed be-
tween 1990 and 2011 and included 1016 patients in total. The study
characteristics are summarised in Table 1.
In all the studies, even though the disease nomenclature may
have varied, the diagnosis was deﬁned using the NIDDK criteria.
The diagnosis of BPS ranged from 11%19e97%,7 with a mean prev-
alence of 61% (58e64%). Five of the studies were prospective in
design. Only one study performed sample size calculations using
Piface software.17 There was a lack of reporting about whether
participants were randomly or purposefully recruited, making it
difﬁcult to assess external validity, although, in three studies par-
ticipants were recruited retrospectively from theatre operating
lists. Seven studies were considered ‘high quality’ (Fig. 2). In one
study routine bladder biopsies were performed when glomer-
ulations were seen on cystoscopy.20 In 44% of these patients,
normal histopathology was noted. In two studies bladder biopsieswere performed; one to rule out carcinoma and in the other where
no cause was identiﬁed on cystoscopy.
The prevalence of endometriosis was given in all nine studies. It
ranged from 28%19e93%,7 with a mean prevalence of 70% (CI 67e
73%) (Fig. 3). It was diagnosed by visual inspection on laparos-
copy with biopsy conﬁrmation of disease performed in 3
studies.6,7,19 In 2 other studies20,21 biopsies were obtained to
conﬁrm the diagnosis of endometriosis where possible. The co-
existence of endometriosis and BPS was given in seven studies.
The prevalence ranged from 16%22e78%,7 with a mean prevalence
of 48% (CI 44e51%) (Fig. 3).
In ﬁve (45%) studies the affected patient group was identiﬁed
through their symptoms and clinical examination. In the other four
studies (44%) validated questionnaires were used; one used the IC
symptom index problem index (O’Leary Sant questionnaire, OLS)
which correlated with the diagnosis of BPS in 94% of patients, two
used thepelvic painurgency/frequency (PUF) questionnaire, showing
higher PUF scores in the BPS patients, and one used both question-
naires to assess the degree of BPS, showing higher scores in the BPS
patients (mean PUF score of 8.6 and OLS score of 7.5).20 Three studies
(33%) used the visual analogue scale questionnaire to assess pain. The
mean pain score for CPP ranged from 5.3e8, and 5.4e7 for BPS.20e225. Discussion
A range of prevalence rates for BPS were reported in the liter-
ature. The large variation in rates observed in this paper may be
explained by the variable study quality and sample selection. The
highest prevalences were noted in patients recruited from
specialist clinics and operating lists. From the nine studies, in 4
studies patients suffered from CPP and urinary symptoms and
notably, some of the highest prevalences of BPS were seen in these
3a: Prevalence of BPS amongst women with CPP 
Prevalence
0 0.2 0.4 0.6 0.8 1
Cheng, 2012 32%    (25% - 40%)
Chung, 2002 97%    (88% - 100%)
Chung, 2005 89%    (84% - 93%)
Clemons, 2002 31 %   (19% - 45%)
Paulson, 2011 81%    (76% - 85%)
Rackow, 2009 39%    (22% - 59%)
Shahmohamady, 2005 28%    (19% - 39%)
Stanford, 2005 11%    (5% - 21%)
Villegas, 2011 59%    (50% - 68%)
Prevalence (95% CI)
61% (58% to 64%)
Inconsistency (I-square) = 97.8 %
High quality
Low quality
3b: Prevalence of endometriosis amongst women with CPP 
Prevalence
0 0.2 0.4 0.6 0.8 1
Cheng, 2012 60%    (52% - 68%)
Chung, 2002 93%    (84% - 98%)
Chung, 2005 75%    (68% - 81%)
Clemons, 2002 47%    (32% - 62%)
Paulson, 2011 78%    (73% - 83%)
Rackow, 2009 64%    (44% - 81%)
Shahmohamady, 2005 88%    (80% - 94%)
Stanford, 2005 28%    (18% - 41%)
Villegas, 2011 65%    (56% - 74%)
70%   (67% to 73%)
Inconsistency (I-square) = 93.0 %
3c: Prevalence of BPS and endometriosis amongst women with CPP 
Prevalence
0 0.2 0.4 0.6 0.8 1
Cheng, 2012 18%    (12% - 25%)
Chung, 2002 78%    (66% - 88%)
Chung, 2002 65%    (57% - 72%)
Clemons, 2002 16 %   (06% - 29%)
*Paulson, 2011 61%    (55% - 67%)
Rackow, 2009 25%    (11% - 45%)
*Shahmohamady, 2005 26%    (17% - 36%)
48%   (44% to 51%)
Inconsistency (I-square) = 96.4 %
* = ‘ low quality’ study
Fig. 3. Prevalences of bladder pain syndrome (BPS), endometriosis and co-existing BPS and endometriosis amongst women with chronic pelvic pain (CPP).
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REVIEWpatients.6,7,14,21 In 6 (67%) of the studies, the authorship team had a
special interest in urogynaecology.
We complied with PRISMA, searched comprehensively, selected
studies and extracted data in duplicate, and synthesised results
appropriately. This systematic reviewhighlights the fact that almost
two thirds of patients presenting with CPP have BPS, a ﬁnding that
merits consideration. In all the studies, the diagnosis was made by
the presence of urinary symptoms and positive cystoscopy ﬁndings.
A limitation is that both cystoscopic normality and bladder lesions
are poorly correlated with histopathology,23 leading to the risk of
misdiagnosis of patients. BPS has a wide symptom spectrum with
imprecise clinical characterisation. Bladder pain or bladder ﬁlling
pain is not captured in the commonly used questionnaires like OLS
and PUF. The value of these questionnaires as a diagnostic tool is
debatable.24 There was limited information about the ethnicity of
the participants in the included studies, which makes it difﬁcult to
apply the results of this review internationally. Literature shows that
the prevalence of BPS does not vary with ethnicity although mi-
nority women appear to be symptomatic for longer than Caucasian
women, while the prevalence of endometriosis appears to be higher
in Asian women than other ethnicities.25e27
Identiﬁcation of BPS is challenging, as the clinical presentation
can be similar to several other conditions,which can lead to delays in
diagnosis and inappropriate treatment. In 2011 the American Uro-
logical Association published guidelines for the diagnosis and man-
agement of IC and BPS, which recommended diagnosis by clinical
history and physical examination, with cystoscopy only used as a
diagnostic tool in complex presentations. Thus allowing initiation of
conservative treatments, such as pain relief, behavioural modiﬁca-
tion and stress management.23 We found an overlap between BPS
andendometriosis. Cliniciansneed to be aware of theexistence of co-
existing pathology and actively investigate urinary symptoms and
BPS as a cause of CPP and commence active management early.
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